FDA
- Status: approved
Individualization of first voriconazole maintenance doses (Individualization of first voriconazole maintenance doses) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
University Hospital, Grenoble is the originator. The local marketing authorisation holder may differ — check the official source linked above.